Want to see JP:9218 full AI Analyst Report?
Top Page
Mental Health Technologies Co. Ltd.
(9218)
Select Model
Select Model
Rating:52Neutral
Price Target:
¥679.00
▼(-17.20% Downside)
Action:Downgraded
Date:02/18/26
The score is primarily supported by improving 2025 fundamentals and cash flow, but is held back by elevated leverage and sharply compressed margins. Technicals are weak with the stock trading below key moving averages and negative MACD, and valuation remains relatively expensive (P/E ~32) with only a modest dividend yield.
Positive Factors
Free cash flow recovery
The strong improvement in operating and free cash flow in 2025 provides durable liquidity to fund operations, invest in product development, and service debt. Free cash flow roughly matching net income implies earnings quality improved, supporting continued reinvestment or balance-sheet repair over months.
Negative Factors
Elevated leverage
Sharp increase in leverage materially limits financial flexibility; higher interest and repayment obligations constrain the company’s ability to invest or absorb shocks. Elevated debt makes the firm more vulnerable to margin pressure and slows capacity for structural deleveraging over the coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
Free cash flow recovery
The strong improvement in operating and free cash flow in 2025 provides durable liquidity to fund operations, invest in product development, and service debt. Free cash flow roughly matching net income implies earnings quality improved, supporting continued reinvestment or balance-sheet repair over months.
Read all positive factors
Mental Health Technologies Co. Ltd. (9218) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥7.73B
Dividend YieldN/A
Average Volume (3M)54.69K
Price to Earnings (P/E)32.0
Beta (1Y)0.75
Revenue Growth17.70%
EPS Growth-27.54%
CountryJP
Employees140
SectorGeneral
Sector StrengthN/A
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)22.99
Shares Outstanding10,507,300
10 Day Avg. Volume35,240
30 Day Avg. Volume54,690
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)5.43
Price to Sales (P/S)1.32
P/FCF Ratio15.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)41.2
Revenue Forecast (FY)¥8.40B
Mental Health Technologies Co. Ltd. Business Overview & Revenue Model
Company Description
Operating in Japan, Mental Health Technologies Co.,Ltd. offers a diverse portfolio of services, encompassing mental wellness solutions, career development assistance for medical professionals, and digital advertising. The company additionally mana...
How the Company Makes Money
null...
Mental Health Technologies Co. Ltd. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
44
Neutral
Cash Flow
66
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.73B | 6.44B | 5.13B | 2.61B | 2.29B | 1.45B |
| Gross Profit | 2.07B | 2.03B | 1.76B | 1.42B | 1.40B | 745.80M |
| EBITDA | 790.05M | 661.94M | 257.58M | 534.92M | 396.89M | 163.06M |
| Net Income | 239.32M | 254.90M | -29.78M | 441.37M | 265.12M | 161.83M |
Balance Sheet | ||||||
| Total Assets | 5.80B | 5.37B | 4.63B | 1.73B | 1.30B | 663.62M |
| Cash, Cash Equivalents and Short-Term Investments | 1.13B | 1.49B | 1.12B | 913.71M | 659.51M | 423.50M |
| Total Debt | 3.07B | 2.62B | 2.57B | 332.49M | 183.77M | 188.52M |
| Total Liabilities | 4.28B | 3.80B | 3.33B | 618.32M | 640.75M | 416.20M |
| Stockholders Equity | 1.53B | 1.57B | 1.29B | 1.12B | 655.37M | 247.42M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 558.09M | 318.71M | 146.70M | 364.78M | 199.36M |
| Operating Cash Flow | 0.00 | 631.99M | 345.90M | 177.54M | 377.49M | 202.14M |
| Investing Cash Flow | 0.00 | -324.30M | -2.15B | -90.61M | -260.33M | -20.79M |
| Financing Cash Flow | 0.00 | 67.82M | 2.00B | 167.28M | 118.85M | 53.33M |
Mental Health Technologies Co. Ltd. Technical Analysis
Positive
820.00
Price Trends
706.16
Positive
724.36
Positive
773.88
Negative
Market Momentum
9.11
Negative
65.10
Neutral
61.58
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9218, the sentiment is Positive. The current price of 820 is above the 20-day moving average (MA) of 715.20, above the 50-day MA of 706.16, and above the 200-day MA of 773.88, indicating a neutral trend. The MACD of 9.11 indicates Negative momentum. The RSI at 65.10 is Neutral, neither overbought nor oversold. The STOCH value of 61.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9218.
Mental Health Technologies Co. Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥1.32T | 26.17 | 12.15% | 1.01% | 23.33% | 21.65% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | ¥12.21B | -25.34 | ― | ― | -39.26% | -69.48% | |
52 Neutral | ¥7.73B | 32.01 | ― | ― | 17.70% | -27.54% | |
51 Neutral | ¥68.81B | 67.94 | 5.76% | ― | 23.30% | -56.05% | |
43 Neutral | ¥2.16B | -4.07 | ― | ― | 18.86% | 38.80% |
* General Sector Average
JP:9218
Mental Health Technologies Co. Ltd.
736.00
101.34
15.97%
JP:2413
M3
1,898.00
96.59
5.36%
JP:4480
Medley
2,102.00
-1,163.00
-35.62%
JP:4263
SUSMED,Inc.
730.00
112.00
18.12%
JP:4438
Welby Inc.
258.00
-108.00
-29.51%
JP:366A
Wellness Communications Corporation
1,093.00
-364.62
-25.01%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.